Aghia Sophia Children's Hospital
- Address
- Thivon and Papadiamantopoulou, 11527 Athens, Greece
Aghia Sophia Children's Hospital - Pediatric Oncology Research
Aghia Sophia Children's Hospital is a leading pediatric medical center with specialized expertise in childhood hematologic malignancies. The institution focuses on advancing treatment protocols for children and adolescents facing complex cancer diagnoses, with particular emphasis on high-risk leukemia cases requiring innovative therapeutic approaches.
- High-risk acute lymphoblastic leukemia (ALL) in relapsed pediatric patients
- CD22-positive B-cell precursor acute lymphoblastic leukemia treatment strategies
- Novel monoclonal antibody therapies including Inotuzumab Ozogamicin in pediatric populations
The center's research programs evaluate cutting-edge induction therapies for children aged 1 to 18 years with first bone marrow relapse of B-cell precursor ALL. By participating in comparative superiority studies, Aghia Sophia Children's Hospital contributes to establishing more effective treatment regimens that may improve remission rates and outcomes for pediatric patients with high-risk leukemia.
Site Overview
Activity Indicator
Last 6 months
Trial Flow
How this site's trials are distributed across therapeutic areas and active substances (IMPs), and how they're positioned within their overall lifecycle status. Flow thickness represents the number of unique trials.
Compounds & Molecules Timeline
The time span of clinical-trial activity for the main active substances (IMPs) studied at this site over the last 8 years. Each bar runs from the earliest trial start to the most recent end; a substance with a trial still open has no recorded end and is shown as ongoing.
Sponsor & Partnership
Top sponsors by active trials, and the ones that have come back for more than one study.
Sponsor Network
Top 1 by active trials.
- 1Pfizer Inc.1active
Partnership History
Sponsors with repeated collaboration (≥ 2 trials).
No repeated partnerships found.
Sponsor Network Graph
How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.
Country Benchmark
Compared to 173 other sites in Greece
Therapeutic Area Benchmark — Greece
Select a therapeutic area to compare against other sites in Greece.
Competitor Comparison
Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.
Country: Greece
Market Share
Country: Greece
Therapeutic Area Market Share
Select a therapeutic area to view its disease coverage breakdown.
Heat Maps & Advanced Analytics
How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.
Other Trials in Aghia Sophia Children's Hospital
| Trial | Sponsor | Phase | Status | Start Date | End Date |
|---|---|---|---|---|---|
| Phase 2 Randomized Study of Inotuzumab Ozogamicin Monotherapy Versus ALLR3 Regimen in Pediatric High-Risk First Relapse CD22-Positive B-Cell Precursor Acute Lymphoblastic Leukemia | Pfizer Inc. | Phase II | Recruiting | May 2023 | — |
IMP list
lock Showing 1 of 8 compounds — the rest is available on a paid plan.
| IMP | Trials | Status | First start | Last start |
|---|---|---|---|---|
| Crisantaspase | 1 | Unknown | 2023-05-13 | 2023-05-13 |
Request feasibility information
Ask this centre about capacity, equipment and patient population.
Upgrade this site to Business Plan
Own the profile, publish your feasibility data and reach sponsors directly.
Is something out of date?
Tell us what needs correcting and we'll update this profile.
lock Available to Business plan sites only.